Novo Nordisk Archives

Generic Semaglutide in India: Affordable Treatment Options

Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Generic Semaglutide Pricing Could Disrupt Global Markets

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Eli Lilly 2026 Guidance Signals Momentum In Obesity Care

Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Wegovy Weight-Loss Pill Offers Injectables Alternative

Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Novo Nordisk Hiring Freeze After Wegovy Sales Decline

Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Ozempic and Mounjaro are reshaping South Africa’s health market

Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Pharmaceutical industry fights to shield drugs from tariffs

Pharmaceutical companies urge the Trump administration and EU to exclude medical goods from tariff wars, warning of potential price hikes and access barriers.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Competition Commission probes insulin price fixing

The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.